Self-Report Versus Performance Measure in Gauging Level of Function with Multiple Sclerosis

Background Multiple sclerosis (MS) is a debilitating, progressive disease with no known cure. Symptoms vary widely for persons with MS and measuring levels of fine motor, gross motor and cognitive function is a large part of assessing disease progression in both clinical and research settings. While self-report measures of function have advantages in cost and ease of administration, questions remain about the accuracy of such measures and the relationship of self-reports of functioning to performance measures of function.